脳と肝臓の軸のヴァーガル阻害は,がんに関連したカシェキアを抑える
Aliesha Garrett1, Naama Darzi2, Ashlesha Deshmukh3
1Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA; Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Cell
|August 8, 2025
まとめ
ガンに関連したカシェキア (CAC) は,脳と肝臓の軸をバグス神経経由で破壊する炎症を伴う. この神経を標的にすることで カケキシアを軽減し,症状を緩和し,化学療法効果を高めることができます.
科学分野:
- 腫瘍学
- 神経科学
- 代謝 疾患
背景:
- 癌に関連したカシェキア (CAC) は,がんによる死亡率と治療抵抗に寄与する複雑な症候群である.
- 癌患者の全身性炎症は既知の要因ですが,特定の神経経路への直接的な影響はまだ調査中です.
研究 の 目的:
- ガンによるカシェキシアにおける ヴァーガル神経の信号伝達の役割を調べるため
- 肝臓の代謝と全身の炎症に対する 管調節障害の影響を調べる
- CACの治療のために迷走神経を標的とした治療戦略を評価する.
主な方法:
- 癌に関連したカシェキシアのマウスモデルを使用した.
- 全身の炎症と静脈の調節の変化を評価した.
- 肝臓のタンパク質代謝とHNF4α発現を分析した.
- 右頸動脈の介入 (外科的,化学的,電気的,皮膚経由)
主要な成果:
- 癌によって引き起こされる炎症は,CACモデルで脳と肝臓の軸を乱します.
- 肝臓の代謝を再プログラムし,炎症を促進します.
- CACの進行と臨床症状を弱めた.
- ネズミの生存率を向上させた.
結論:
- 迷走神経は脳と肝臓の軸を通して 癌に関連したカシェキアを媒介する上で 重要な役割を果たします
- 神経活性の調節は,CACに対する有望な治療戦略です.
- 非侵襲的な神経刺激は 癌治療に役立つかもしれません
関連する概念動画
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
259
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
259
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
366
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
366
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
443
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
443
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
322
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
322
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Psychoneuroimmunology: Diabetes and Cancer
62
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
62


